Worldometer is run by an international team of developers, researchers, and volunteers with the goal of making world statistics available in a thought-provoking and time relevant format to a wide audience around the world. It is published by a small and independent digital media company based in the United States. They have no political, governmental, or corporate affiliation. Furthermore, they have no investors, donors, grants, or backers of any type. Worldometer is completely independent and self-financed through automated programmatic advertising sold in real time on multiple ad exchanges.
For the COVID-19 data, they collect data from official reports, directly from Government's communication channels or indirectly, through local media sources when deemed reliable. Timely updates are made possible thanks to the participation of users around the world and to the dedication of a team of analysts and researchers who validate data from an ever-growing list of over 5,000 sources.
The Worldometer website provides great insight in the spread and effects of the coronavirus worldwide.
The Center for Systems Science and Engineering (CSSE) is a research collective housed within the Department of Civil and Systems Engineering (CaSE) at Johns Hopkins University (JHU). Our faculty, researchers, and students work on a range of complex and interdisciplinary problems, united by the goal to better understand and improve societal, health, and technological systems for everyone.
They have created an extensive COVID-19 dashboard.
Het dashboard coronavirus is ontwikkeld door het ministerie van VWS. Het geeft informatie over de ontwikkeling van het coronavirus in Nederland. Met deze informatie kunnen signalen van oplevingen worden opgepikt. Zo kunnen maatregelen genomen worden om het virus te stoppen.
De gegevens op het dashboard worden dagelijks bijgewerkt. Dat doen we voor het grootste deel op basis van open-databestanden van het RIVM. Het RIVM zet dagelijks om de bijgewerkte gegevens online.
ELSO is providing an enormous amount of information on COVID and ECMO treatment.
ELSO is providing this website as a resource for centers who may be called on to manage COVID-19 patients. As this is an emerging infectious disease, the scientific data is constantly evolving. The contents of this page will change rapidly as new information develops. For real time updates, please follow ELSO’s social media accounts at Twitter (@ELSOOrg and @ECMOed) and Facebook (https://www.facebook.com/ELSO.Org) as well as the ECMOed COVID-19 page (https://elso.blog/category/2019ncov-2/)
ELSO has setup an international registry for ECLS/ECMO procedures in COVID-19 treatment and published guidelines in treatment.
Representatives from the American Society of ExtraCorporeal Technology, the American Board of Cardiovascular Perfusion, the American Academy of Cardiovascular Perfusion, the Asociación Latinoamericana de Perfusión, the Australian and New Zealand College of Perfusionists, the Canadian Society of Clinical Perfusion, Comprehensive Care Services, the European Board of Cardiovascular Perfusion, the Michigan Society of Thoracic and Cardiovascular Surgeons, Perfusion.com, the Society of Clinical Perfusion Scientists Great Britain and Ireland, SpecialtyCare, Tiny Perfusion Letter, and Vivacity Perfusion have formed the Joint Perfusion COVID-19 Task Force to monitor the recent coronavirus outbreak and its impact on our community. Combining the strengths of all organizations, our goal is to disseminate information and resolve questions related to perfusionists and COVID-19.
The COVID-19 Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information become available.
The recommendations in these Guidelines are based on scientific evidence and expert opinion.